Why Do the Majority of Submissions for Bridging from a Prefilled Syringe to an Autoinjector Include Bioequivalence Studies in Order to Demonstrate Comparability?

William J. Lambert

Open source

DOI
10.1208/s12248-020-00453-0
Published
2020-05
Container
The AAPS Journal
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1208/s12248-020-00453-0,
  title = {Why Do the Majority of Submissions for Bridging from a Prefilled Syringe to an Autoinjector Include Bioequivalence Studies in Order to Demonstrate Comparability?},
  author = {William J. Lambert},
  year = {2020},
  journal = {The AAPS Journal},
  doi = {10.1208/s12248-020-00453-0},
  url = {https://doi.org/10.1208/s12248-020-00453-0}
}

RIS

TY  - JOUR
TI  - Why Do the Majority of Submissions for Bridging from a Prefilled Syringe to an Autoinjector Include Bioequivalence Studies in Order to Demonstrate Comparability?
AU  - William J. Lambert
PY  - 2020
JO  - The AAPS Journal
DO  - 10.1208/s12248-020-00453-0
UR  - https://doi.org/10.1208/s12248-020-00453-0
ER  - 

APA

Lambert, W. J. (2020). Why Do the Majority of Submissions for Bridging from a Prefilled Syringe to an Autoinjector Include Bioequivalence Studies in Order to Demonstrate Comparability?. The AAPS Journal. https://doi.org/10.1208/s12248-020-00453-0

Source records